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Summary
 
Mice deficient in various mismatch repair (MMR) enzymes were examined to determine
whether this repair pathway is involved in antibody class switch recombination. Splenic B cells
from mice deficient in Msh2, Mlh1, Pms2, or Mlh1 and Pms2 were stimulated in culture with
lipopolysaccharide (LPS) to induce immunoglobulin (Ig)G2b and IgG3, LPS and interleukin
(IL)-4 to induce IgG1, or LPS, anti–
 
d
 
-dextran, IL-4, IL-5, and transforming growth factor
(TGF)-
 
b
 
1 to induce IgA. After 4 d in culture, cells were surface stained for IgM and non-IgM
isotypes and analyzed by FACS
 
®
 
. B cells from MMR-deficient mice show a 35–75% reduction
in isotype switching, depending on the isotype and on the particular MMR enzyme missing.
IgG2b is the most affected, reduced by 75% in Mlh1-deficient animals. The switching defect is
not due to a lack of maturation of the B cells, as purified IgM
 
1
 
IgD
 
1
 
 B cells show the same re-
duction. MMR deficiency had no effect on cell proliferation, viability, or apoptosis, as detected
 
by [
 
3
 
H]thymidine incorporation and by propidium iodide staining. The reduction in iso-
type switching was demonstrated to be at the level of DNA recombination by digestion-circu-
larization polymerase chain reaction (DC-PCR). A model of the potential role for MMR en-
zymes in class switch recombination is presented.
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A
 
ctivation of mature B lymphocytes which express IgM
and IgD on their surface leads to the expression of
downstream Ig heavy chain genes that confer different ef-
fector functions upon the antibody molecule while main-
taining the same antigen-binding V domain. This process
occurs by means of an intrachromosomal, deletional DNA
recombination event between switch (S)
 
1
 
 regions located
5
 
9
 
 of each heavy chain C region gene except C
 
d
 
. The S re-
gions consist of 1–10 kb stretches of tandemly repeated
G-rich sequences. The mechanism of class switch recombi-
nation (CSR) and the enzymes involved in cutting, align-
ing, and ligating the DNA during CSR are all unknown.
Since S regions do not share significant stretches of iden-
tity, CSR is not thought to involve homologous recombi-
nation, as this requires 
 
z
 
200 nucleotides (nt) of identity
between recombining sequences (1, 2). Sequence identities
between the donor S and acceptor S region are found at
the sites of recombination, but they are very short (3) and
are typical of illegitimate recombination or end-joining re-
actions (4). Induction of double-strand breaks (DSBs) is
thought to initiate switch recombination (5), and compo-
nents of the Ku complex, which are required for DSB repair,
are also required for switch recombination (6–8). The nt ex-
cision repair protein, XP-C, is not required for CSR (9).
We have examined whether mismatch repair (MMR)
enzymes may play a role in CSR. Aside from the repair of
mispaired bases due to DNA polymerase errors, these en-
zymes are also involved in recombination. MMR enzymes
recognize DNA distortions—they bind to Holliday junc-
tions (10) and heteroduplex DNA (11). MMR enzymes can
suppress recombination between divergent sequences (12,
13) and are involved in the removal of heterologous DNA
at the ends of homologous recombining segments (14). In
addition, several groups have reported that mice deficient
in the MMR enzymes Mlh1, Pms2, or Msh2 have reduced
levels and/or an altered pattern of somatic mutation in the
V region genes (15–19). V gene somatic hypermutation re-
sults in small insertions, deletions, and point mutations sim-
 
1
 
Abbreviations used in this paper: 
 
AchR, acetylcholine receptor; CSR, class
switch recombination; DC-PCR, digestion-circularization PCR; DSB,
double strand break; GC, germinal center; MMR, mismatch repair; nt, nu-
cleotide(s); PALS, periarteriolar lymphatic sheath; S, switch; wt, wild-type. 
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ilar to those found surrounding the sites of switch recombi-
nation (3, 20, 21). Both somatic mutation and CSR occur
with similar kinetics after B cell activation (22) and occur
in germinal centers (GCs), although CSR also occurs in the
T cell–rich areas of the spleen and lymph nodes (22, 23).
MMR enzymes are known to be expressed and are func-
tional in human tonsil GCs (24). In addition to altered so-
matic hypermutation, it has been observed that Msh2-defi-
cient mice have reduced antigen-specific T-dependent serum
IgG responses (18, 25), T-independent IgG3 responses (25),
and also reduced numbers of IgG antibody-forming cells in
the periarteriolar lymphatic sheath (PALS [25]). Increased
apoptosis occurs in GCs of Msh2
 
2
 
/
 
2
 
 mice and has been pro-
posed to account for the reduced secondary responses in
these mice (25). Alternatively, we propose that impaired
CSR could directly account for the reduced IgG expression
in Msh2
 
2
 
/
 
2
 
 mice.
To test this alternative hypothesis, we asked whether de-
ficiencies in MMR enzymes would alter the ability of B
cells to undergo isotype switching in vitro. We measured
class switching by surface staining for expression of IgM
and non-IgM isotypes, and also at the DNA level by diges-
tion-circularization PCR (DC-PCR). We found no im-
pairment in the ability of MMR-deficient cells to divide
and survive in culture; however, CSR by these cells is seri-
ously compromised.
 
Materials and Methods
 
Mice.
 
Mice made deficient in Pms2 and Mlh1 by gene target-
ing were obtained from R.M. Liskay, Oregon Health Sciences
University, Portland, OR (26, 27). Mice heterozygous for 
 
mlh1
 
and 
 
pms2
 
 were mated to generate mice heterozygous at both the
 
mlh1
 
 and 
 
pms2
 
 loci. These double heterozygotes were then mated
to generate mice homozygous for the null mutation at both loci.
 
msh2
 
 mutant mice were generated by replacing exon 7 with a neo-
mycin cassette (Hofland, N., R. Smits, W. Edelmann, R. Kucherla-
pati, and R. Fodde, manuscript in preparation). The phenotype of
these mice resembles that of previously described 
 
msh2 
 
mutant
mouse lines (28, 29). All mouse strains were carried as heterozy-
gotes, and wild-type (wt) littermates were used as controls.
 
Cells and Cell Culture.
 
B cells were isolated from spleens by
depletion of RBCs by lysis in Gey’s solution for 5 min on ice and
by depletion of T cells with a cocktail of anti-T cell reagents, anti-
CD4 (GK1.5), anti-CD8 (3.168), and anti-Thy1 (HO13.4 and
J1J10), followed by anti–rat 
 
k
 
 chain mAb (MAR18.5) and guinea
pig complement (Pelfreeze Biochem). Viable cells were isolated
by flotation on Ficoll/Hypaque gradients (
 
d 5
 
 1.09). 10
 
6
 
 B cells
were cultured at 2 
 
3 
 
10
 
5
 
/ml in 6-well plates for 4 d in RPMI
1640 (BioWhittaker), with 10% FCS (Hyclone), 2 mM 
 
l
 
-gluta-
mine, 100 U/ml penicillin, 100 
 
m
 
g/ml streptomycin (all from
GIBCO BRL), and 5 
 
3
 
 10
 
2
 
5
 
 M 2-ME (Sigma Chemical Co.). LPS
(50 
 
m
 
g/ml; Sigma Chemical Co.), recombinant murine (rm)IL-4
(800 U/ml; gift of W. Paul, National Institutes of Health, Bethesda,
MD), rmIL-5 (150 U/ml; PharMingen), human TGF-
 
b
 
1 (2 ng/ml;
R&D Systems), and anti–
 
d
 
-dextran (0.3 ng/ml; gift of C. Snapper,
Uniformed Services University of the Health Sciences, Bethesda,
MD) were added at the initiation of culture. In one experiment (see
Table II), a combination of LPS plus dextran sulfate (30 
 
m
 
g/ml;
Amersham Pharmacia Biotech) was used to induce IgG2b.
 
FACS
 
®
 
 Analysis.
 
Before staining, cells were given a brief acid
treatment to remove Fc receptor–bound Ig (30). Pelleted cells
were drained and resuspended in 500 
 
m
 
l of 50 mM NaOAc, pH
5.2, 85 mM NaCl, 5 mM KCl, 1% FCS. After 2 min on ice, cells
were washed twice in FACS buffer (PBS, 1% FCS, 0.2% NaN
 
3
 
)
and stained for FACS
 
®
 
 analysis. FITC-goat anti–mouse IgM, PE-
goat F(ab
 
9
 
)
 
2
 
 anti–mouse IgG1, IgG2b, and IgG3, and PE-goat
anti–mouse IgA were all purchased from Southern Biotechnol-
ogy Associates. PE-anti–mouse IgD
 
b
 
 was purchased from Phar-
Mingen. Cells were analyzed on a FACScan™ (Becton Dickinson)
and gated on live lymphocytes based on forward and side scatter.
IgM
 
1
 
IgD
 
1
 
 cells were sorted by FACS
 
®
 
 and were 90–95% pure;
contaminating cells were mostly IgM
 
 
 
negative.
 
Analysis of DNA Synthesis, Cell Viability, and Cell Cycle.
 
To
measure cell division, cells were cultured at 10
 
5
 
/ml for 3 d. Dur-
ing the final 4 h, each well was pulsed with 1 
 
m
 
Ci [
 
3
 
H]thymidine
(2 Ci/mmol; ICN). Plates were harvested onto filter-mats (Wal-
lac) and read on a 1205 Betaplate (LKB/Wallac). Data shown are
the mean cpm of triplicate wells. For apoptosis and cell cycle
analysis, cultured cells were pelleted, fixed in 70% ethanol for
 
.
 
24 h, resuspended in a buffer to facilitate extraction of low mo-
lecular weight DNA (nine parts 0.05 M Na
 
2
 
HPO
 
4
 
, and one part
25 mM citric acid, containing 1% Triton X-100), and stained
Figure 1. Splenic B cells from MMR-deficient mice incorporate
[3H]thymidine as well as wt littermates. B cells were cultured under con-
ditions used to induce isotype switching for 3 d and pulsed for the final 4 h
with [3H]thymidine before harvesting. A representative of three separate
experiments is shown. 
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with 20 
 
m
 
g/ml propidium iodide for FACS
 
®
 
 analysis according
to Hotz et al. (31). Modfit cell cycle analysis was used for quanti-
tation.
 
DC-PCR.
 
Genomic DNA was isolated from cells cultured
for 4 d under conditions used for switching analysis. DC-PCR
was performed as described (32). In brief, DNA was digested
with EcoRI overnight (2 
 
m
 
g/100 
 
m
 
l) and then ligated overnight
(180 ng/100 
 
m
 
l) with T4 ligase (400 U; New England Biolabs).
Circularized DNA was then dialyzed against deionized dH
 
2
 
O
(0.05-
 
m
 
m VMWP filters; Millipore) before PCR analysis. PCR
primers and conditions were as described for acetylcholine recep-
tor (AchR) and IgG1 (32) and IgG2b (33), except that HotStar
Taq DNA polymerase (QIAGEN) was used. Plasmid standards
P2A0 and P4AP (32) were used as templates with the primers for
AchR and IgG1, respectively, to determine the PCR conditions
under which the amount of product depends on the amount of
input template in a linear fashion. Radiolabeled PCR products
were analyzed on 8% polyacrylamide gels, dried, and exposed to
X-ray film overnight at room temperature. Densitometry was
performed on films with a Personal Densitometer SI (Molecular
Dynamics). For quantitation, the amounts of S
 
m
 
-
 
g
 
1 and S
 
m
 
-
 
g
 
2b
PCR products were normalized to the amount of AchR product.
 
Results
 
To evaluate whether MMR enzymes are involved in
CSR, T-depleted spleen cells were isolated from mice defi-
cient in one or more of the MMR enzymes and assessed
for ability to undergo isotype switching in vitro. Our anal-
ysis included mice made deficient by targeted gene replace-
ment in the MutS homologue Msh2, and the MutL homo-
logues Mlh1 and Pms2. Splenic B cells from MMR-deficient
mice or their wt littermates were stimulated in culture with
 
either LPS to induce IgG2b and IgG3, LPS and IL-4 to in-
duce IgG1, or LPS, anti–
 
d
 
-dextran, IL-4, IL-5, and TGF-
 
b
 
1
to induce IgA.
 
Analysis of Proliferation, Cell Cycle, and Cell Viability.
 
As
isotype switching is dependent on cell division (34), we first
determined whether the MMR-deficient cells could syn-
thesize DNA and cycle at the same rate as wt cells, and
whether or not they were more prone to cell death. We
used two methods to examine these questions. First, [
 
3
 
H]
thymidine incorporation was used to measure DNA syn-
thesis. MMR-deficient cells cultured under all three condi-
tions used to induce isotype switching showed no differ-
ence in [
 
3
 
H]thymidine incorporation compared with wt
cells (Fig. 1). Second, cells cultured for 2 or 4 d were
stained with propidium iodide to quantify the percentage
of cells in cycle and the amount of apoptosis during the
culture period. MMR-deficient cells were indistinguishable
from wt cells cultured under all three conditions with re-
gard to both the percentage of cells in cycle and the per-
centage of cells undergoing apoptosis on day 2 (Table I)
and on day 4 (not shown). In addition, recovery of viable
cells on day 4 was similar between wt and MMR-deficient
cultures (Table I). We conclude that MMR-deficient B
cells divide and survive in culture as well as wt cells.
 
FACS
 
®
 
 Analysis Demonstrates Reduction of Class Switching in
B Cells from MMR-deficient Mice.
 
Isotype switching was
measured after 4 d in culture with the stimulators described
above. Cells were surface stained with FITC–anti-IgM and
PE–anti-isotype reagents for FACS
 
®
 
 analysis. A representa-
tive experiment using B cells from a mouse deficient in both
Mlh1 and Pms2 is shown in Fig. 2. The specificity of the
 
Table I.
 
Cell Cycle Analysis of Wt and MMR-deficient B Cells on Day 2
 
B cells Treatment
Percentage of cycling cells
in each phase on day 2 Percentage of
apoptotic cells
on day 2 (
 
,
 
2n
 
*
 
)
Viable cell
recovery
on day 4 G
 
0
 
/G
 
1
 
SG
 
2
 
/M
 
3
 
10
 
2
 
6
 
Wt-msh LPS 33.6 50.2 16.2 3.4 8.4
Pms2
 
2
 
/
 
2
 
29.5 48.3 22.2 1.6 7.7
Mlh1
 
2
 
/
 
2
 
32.4 48.6 19.1 1.4 9.5
Wt-pms2 30.5 48.4 21.1 1.9 14.6
Wt-msh LPS 
 
1
 
 IL-4 38.3 45.4 16.3 3.3 9.6
Msh2
 
2
 
/
 
2
 
34.6 47.8 17.6 2.6 7.7
Pms2
 
2
 
/
 
2
 
35.2 45.0 19.8 1.9 7.2
Mlh1
 
2
 
/
 
2
 
36.9 45.0 18.1 1.7 8.6
Wt-pms2 33.9 50.4 15.7 2.7 6.8
Wt-msh LPS 
 
1
 
 
 
a
 
–
 
d
 
 dextran 50.8 37.8 11.4 1.8 7.2
Msh2
 
2
 
/
 
2
 
48.6 41.2 10.2 0.8 9.0
Pms2
 
2
 
/
 
2
 
49.7 39.7 10.6 0.9 7.1
Mlh1
 
2
 
/
 
2
 
52.8 35.3 11.9 1.1 8.7
Wt-pms2 52.1 37.5 10.4 1.2 7.4
 
*
 
Percentage of total cells with 
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staining reagents and the induction of switching are dem-
onstrated in the first two columns with wt B cells. LPS and
IL-4, but not LPS alone, induce switching to IgG1. LPS
induces switching to IgG3 and IgG2b, but addition of IL-4
downregulates switching to these isotypes. Comparison of
the second and third columns shows that switching to all
isotypes is reduced in B cells from Mlh12/Pms22 mice.
44% of wt B cells expressed IgG1, compared with only
23% of Mlh12/Pms22 B cells. IgG3 and IgA were also re-
duced by z50%. IgG2b was reduced even more, as 12% of
wt B cells expressed IgG2b, compared with only 3% of
Mlh12/Pms22 B cells.
The results of many such experiments with Mlh1-,
Pms2-, Mlh1-/Pms2-, and Msh2-deficient B cells are shown
in Fig. 3. Compared with wt B cells, switching to all iso-
types is reduced in B cells from all MMR-deficient mice.
The extent of the reduction varies between isotypes, as well
as between the different enzyme deficiencies. IgG1 and IgG3
are reduced by 1.6–2-fold, while IgG2b is the most affected
isotype, reduced by 2–4-fold. IgA is reduced by two- to
threefold. IgG1 and IgG2b are reduced more in Mlh1-defi-
cient B cells than in Pms2-deficient cells (P , 0.05 and P ,
0.0005, respectively). Switching by Mlh12/Pms22 B cells
is similar to that by B cells deficient only in Mlh1. These
data are consistent with the fact that Mlh1 functions as part
of an Mlh1/Pms2 heterodimer, and also in another hetero-
dimer with Mlh3 (35).
It has been reported that Msh2-deficient mice have re-
duced numbers of mature IgM1IgD1 B cells (18, 25), and
it was possible that this was the cause of the reduced ability
of these cells to undergo isotype switching. We analyzed
the percentage of spleen cells that are IgM1IgD1 from the
MMR-deficient mice by FACS® and found a small but re-
producible decrease compared with wt mice (Table II). To
determine if the decrease in isotype switching might be due to
this decrease in mature B cell number, we sorted IgM1IgD1
cells from MMR-deficient and from wt mice by FACS®
and determined the ability of these mature B cells to switch
compared with unsorted T-depleted spleen cells. Isotype
switching by the IgM1IgD1 sorted population was compa-
rable to switching by T-depleted spleen cells, and switch-
ing was reduced in MMR-deficient mature IgM1IgD1
cells compared with wt. Again, IgG2b was reduced more
than IgG1 (Table II).
MMR Deficiency Reduces Class Switching at the Level of
DNA Recombination. To verify that the decrease in iso-
type switching occurs at the level of DNA recombination,
we used a quantitative DC-PCR assay to measure switch
recombination (32). After EcoRI digestion of genomic
DNA, Sm and Sg2b or Sm and Sg1 reside on the same DNA
fragment if switching to that isotype has occurred. To de-
tect these fragments, EcoRI-digested genomic DNA was
ligated under dilute conditions to form circles, and then
primers directing PCR amplification across the ligated
EcoRI junctions were used to generate PCR products of
uniform size, independent of where recombination took
place within the switch regions. Primers specific for a con-
Figure 2. Representative FACS® analysis of splenic B cells from wt and
Mlh1-/Pms2-deficient mice induced to switch in vitro. The first column
(negative control) shows cells stimulated under conditions that do not in-
duce the indicated isotype. Induced switching by wt cells (second column)
is compared with switching by Mlh12/Pms22 B cells (third column).
Figure 3. MMR deficiency reduces isotype switching by 35–75%.
Data are compiled from several experiments with mutant mice and their
wt littermates. Mlh12 (n 5 4) and Pms22 (n 5 5), error bars show 1 SD;
Mlh12/Pms22 and Msh22 (n 5 2), error bars show range.327 Schrader et al.
trol EcoRI fragment that does not undergo rearrangement
(AchR) were used to control for the efficiency of the di-
gestion and circularization. Plasmid standards for AchR and
Sg1 (32) were used to establish PCR conditions in the lin-
ear range. As shown by serial dilution of standards and sam-
ples in Fig. 4, the amount of the PCR products depended
on the amount of template added. For quantitation (Table
III), the Sm-Sg2b and Sm-Sg1 DC-PCR results were nor-
malized to the amount of AchR product.
The DC-PCR analysis indicated that the frequency of
Sm-Sg2b switch recombination in Pms22 and Mlh12/
Pms22 B cells was three- to eightfold lower than in wt B
cells (Fig. 4 and Table III). The reduction in Sm-Sg1 re-
combination was less dramatic, but still detectable in Pms22
and Mlh12/Pms22 cells. Quantitation of the FACS® and
DC-PCR data (Table III) shows that the two methods
compare reasonably well, and that IgG2b is more severely
affected than IgG1 by both assays. We conclude that the
reduction in isotype switching observed in MMR-deficient
B cells occurs at the level of DNA recombination.
Discussion
We have found that deficiency in any of three MMR
enzymes, Mlh1, Pms2, or Msh2, results in a decrease in iso-
type switching in vitro. By FACS® analysis of surface Ig,
the effect ranged from a 35% decrease in IgG1 in Pms22/2
and Msh22/2 B cells to a 75% decrease in IgG2b in Mlh12/2
B cells, the average reduction being 50%. This decrease was
shown to occur at the level of DNA recombination by DC-
Table II. Isotype Switching Is Decreased in MMR-deficient IgM1IgD1 Mature B Cells
Percentage of B cells Percentage of wt switching*
IgM1IgD1 IgG1 (LPS 1 IL-4) IgG3 (LPS) IgG2b (LPS 1 DS) IgG2b (LPS 1 TGF-b)
Msh22 T-depleted 62 –‡ 48 58
IgM1IgD1 79 88 55 44 66
Mlh12 T-depleted – – – –
IgM1IgD1 80 61 88 22
Pms22 T-depleted – – – –
IgM1IgD1 71 69 55 – –
Mlh12/Pms22 T-depleted 47 – 48 28
IgM1IgD1 85 50 – 31 44
Wt T-depleted 100 100 100 100
IgM1IgD1 88 100 100 100 100
*Data are combined from two experiments; treatments in parentheses. DS, dextran sulfate.
‡Not done.
Figure 4. DC-PCR analysis demonstrates that switch recombination is
reduced at the DNA level in MMR-deficient mice. Standard shown is a
titration (threefold dilution) of plasmids P2A0 and P4AP with the same
primers used to detect AchR and Sm-Sg1, respectively. Titration of sam-
ple templates was by twofold dilutions. DC-PCR for Sm-Sg1 and Sm-
g2b was repeated on these same samples, as well as on samples from
Msh22 cells (not shown), with similar results.
Table III. Comparison of Results from DC-PCR and FACS® 
Analyses from the Same Experiment
IgG2b IgG1
DC-PCR* FACS® DC-PCR FACS®
%
Pms22 24 41 72 59
Mlh12/Pms22 12 34 69 52
*DC-PCR data are normalized to the AchR data, and presented as
percent of wt.328 Reduced Isotype Switching in Mismatch Repair–deficient B Cells
PCR analysis. Although MMR-deficient B cells are capable
of isotype switching, the process is clearly less efficient.
We found no evidence that MMR deficiency has any ef-
fect on the ability of B cells to grow and to enter cell cycle
in response to the stimulation conditions used to induce
isotype switching. It has been reported that Msh2-deficient
mice have decreased numbers of mature IgM1IgD1 B cells
(18). However, this decrease is observed predominantly in
the bone marrow, and only marginally in the spleen (25).
We found there to be an average of 10% fewer IgM1IgD1
B cells in spleens from MMR-deficient mice, and when
sorted by FACS®, these mature B cells also have the phe-
notype of reduced isotype switching in vitro.
It has been observed at day 8 after immunization that
GCs from msh22/2 mice were smaller than wt and showed
increased apoptosis relative to wt mice (25). The authors
suggest that the reduction in IgG antibody-forming cells in
the PALS and IgG production in these mice may be ex-
plained by the death of cells that undergo high rate prolif-
eration. However, increased apoptosis was only observed
in vivo; no increase in apoptosis or decrease in proliferation
was observed in msh22/2 B cells in vitro by these authors.
Thus, it is possible that the apoptosis observed in vivo is an
indirect effect of the msh2 mutation. Msh2-deficient mice
were found to have normal T cell populations and normal
architecture of PALS and spleen, including GC formation
and follicular dendritic cell (FDC) network, suggesting the
effect is on the B cells themselves (25). However, it is pos-
sible that the apoptosis detected in GCs may be related to a
lack of positive selection due to the altered somatic muta-
tion of V region genes observed in msh22/2 mice (16–18).
Decreased somatic hypermutation should lead to a decrease
in antibody affinity maturation, consistent with the finding
that msh22/2 mice show no memory response upon sec-
ondary immunization (25). We conclude that the decrease
in IgG responses in msh22/2 mice is a direct result of im-
paired CSR.
We have developed a model demonstrating a possible
role for MMR enzymes in switch recombination (Fig. 5).
The model is based on an illegitimate priming mechanism
for CSR (3, 21). In our model, CSR is initiated by DSBs,
and occurs by an end-joining type of recombination in
which a single-strand end from one S region uses bits of
homology to prime DNA synthesis on the other, and vice
versa. Small stretches of identity at switch region junctions
range from only 1 to 5 nt, yet microhomologies on this or-
der have been proposed to prime DNA synthesis for gap
filling as a mechanism for end-joining (36). As the 39 ends
must have perfectly paired nt in order to prime DNA syn-
thesis, heterologous DNA surrounding the DSB must be
removed.
We hypothesize that MMR enzymes may be involved in
processing the 39 ends produced by DSBs based on experi-
ments performed in Saccharomyces cerevisiae. Sugawara et al.
(14) showed that the MMR genes msh2 and msh3 are re-
quired for removal of nonhomologous DNA surrounding a
DSB in order to reach the region homologous to the tem-
plate for the repair of the DSB. Msh2 and 3 are essential for
DSB repair when the heterologous DNA segment is 30 nt
or greater in length (37). However, if the segment is only
20 nt long, repair is inhibited by 50–70% and if 10 nt long,
by 15% in the msh2-deficient yeast. DNA polymerase d
was found to contribute to removal of shorter stretches of
nonhomology (37). The mechanism of the removal of non-
homologous ends in yeast requires the Rad1–Rad10 com-
plex, an endonuclease physically associated with Msh2.
Thus, we propose that the role of MMR enzymes in CSR
may be to produce 39 single-strand ends capable of priming
DNA synthesis by removing heterologous DNA to expose
a few nt complementary to the other S region. The micro-
homology used for priming DNA synthesis may result in
the short bits of identity observed at the S–S junctions (3).
This model provides several possible explanations for
why CSR is not completely inhibited in the MMR-defi-
cient B cells. It is possible that DNA polymerase d or an
exonuclease, such as the B cell–specific exonuclease BCAN
(38), could partially substitute in the absence of MMR en-
zymes. In addition, 39 end-processing may not be required
for switch events when an adequate microhomology be-
tween the two combining S regions exists very near the
sites of the DSB. The finding that some isotypes are more
dependent on MMR enzymes than others may be due to
the fact that the sequences of different S regions differ, and
thus their dependence on 39 end-processing may differ. Fi-
nally, the redundancy among different MMR enzymes is
not well understood. This redundancy might vary depend-
ing on the particular function of the MMR enzyme and
Figure 5. Model for a possible role for MMR enzymes in isotype
switch recombination. This model for CSR (references 3 and 21) is simi-
lar to a model for end-joining in Xenopus laevis oocytes proposed by Leh-
man et al. (reference 36), involving gap repair DNA synthesis primed by
microhomologies. MMR enzymes may be involved in 39 end-processing
to remove nonhomologous DNA surrounding a DSB in order to reach
bits of identity that can be used to prime DNA synthesis in an end-joining
reaction. In S. cerevisiae, Msh2 is required for the removal of heterologous
39 ends .30 nt in length during DSB-induced recombination between
homologous sequences (reference 37).329 Schrader et al.
might help to account for the differential dependence of
CSR on the three MMR enzymes examined here.
In yeast, Msh2, but not Mlh1 or the homologue of Pms2
(yeast Pms1), is required for the removal of heterologous
sequences surrounding a DSB in order to repair it by ho-
mologous recombination (14). This result differs from our
finding that deletion of any of the three genes for MMR
enzymes that we tested results in a reduction in CSR. We
propose two possible explanations for this difference. CSR
differs from homologous recombination, as it does not
involve recombination between homologous sequences.
Whether the end-joining type of recombination in yeast
requires MMR enzymes has not been reported. In addi-
tion, although yeast and mammalian MMR enzymes have
been shown to be similar, they are not identical, and thus
some of their functions might differ.
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